Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/12137
Title: Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials
Authors: Shi, Qian
Renfro, Lindsay A.
Bot, Brian M.
BURZYKOWSKI, Tomasz 
BUYSE, Marc 
Sargent, Daniel J.
Issue Date: 2011
Publisher: ELSEVIER SCIENCE BV
Source: COMPUTATIONAL STATISTICS & DATA ANALYSIS, 55 (9). p. 2748-2757
Abstract: Various meta-analytical approaches have been applied to evaluate putative surrogate endpoints (S) of primary clinical endpoints (T), however a systematic assessment of their performance is lacking. Existing methods in the meta-analytic framework can be grouped into two types conventional and model-based trial-level surrogacy (TLS) measures. Both conventional and model-based TLS measures assess the ability to predict the treatment effect on T based on an observed treatment effect on putative S. Conventional TLS measures include correlation coefficients and R-square measures from weighted linear regression. Model-based TLS includes Copula R(2) proposed by Burzykowski et al. (2001). We examined and compared the estimation performance of these frequently used surrogacy measures in a large-scale simulation study. The impact of several key factors on the estimation performance was assessed, including the strength of the true surrogacy, the amount of effective information provided by available data, and the range of within-trial treatment effect on S and T. The TLS can be estimated accurately and precisely by both types of surrogacy measures when the true surrogacy is strong, number of trials is large, and the range of within-trial treatment effects is wide. When one or more factors deviate from the "best" scenarios, both types of TLS measures tend to underestimate the true surrogacy with increased variability. The estimation performance of conventional measures is similar to model-based measures, but with higher computational efficiency. The findings are applied to a large individual patient data pooled analysis in colon cancer. (C) 2011 Elsevier B.V. All rights reserved.
Notes: [Shi, Q; Bot, BM; Sargent, DJ] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA [Renfro, LA] Baylor Univ, Dept Stat Sci, Waco, TX 76798 USA [Burzykowski, T; Buyse, M] Hasselt Univ, I BioStat, Diepenbeek, Belgium [Burzykowski, T; Buyse, M] Int Inst Drug Dev, Louvain, Belgium shi.qian2@mayo.edu
Keywords: Clinical trials; Meta-analysis; Survival analysis; Trial-level surrogacy;Clinical trials; Meta-analysis; Survival analysis; Trial-level surrogacy
Document URI: http://hdl.handle.net/1942/12137
ISSN: 0167-9473
e-ISSN: 1872-7352
DOI: 10.1016/j.csda.2011.03.014
ISI #: 000291916100017
Category: A1
Type: Journal Contribution
Validations: ecoom 2012
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
Comparative assessment.pdfarticle181.21 kBAdobe PDFView/Open
Show full item record

SCOPUSTM   
Citations

25
checked on Sep 5, 2020

WEB OF SCIENCETM
Citations

26
checked on May 22, 2022

Page view(s)

78
checked on May 20, 2022

Download(s)

216
checked on May 20, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.